Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $1.36 in the prior trading day, MAIA Biotechnology Inc (AMEX: MAIA) closed at $1.48, up 8.82%. In other words, the price has increased by $8.82 from its previous closing price. On the day, 0.55 million shares were traded. MAIA stock price reached its highest trading level at $1.48 during the session, while it also had its lowest trading level at $1.355.
Ratios:
Our goal is to gain a better understanding of MAIA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.18 and its Current Ratio is at 1.18. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 22 ’25 when Smith Stan bought 57,189 shares for $1.22 per share. The transaction valued at 69,999 led to the insider holds 1,421,478 shares of the business.
CHAOUKI STEVEN M bought 40,849 shares of MAIA for $49,999 on Dec 22 ’25. The Director now owns 151,873 shares after completing the transaction at $1.22 per share. On Dec 22 ’25, another insider, Louie Ngar Yee, who serves as the Director of the company, bought 81,699 shares for $1.22 each. As a result, the insider paid 100,000 and bolstered with 1,248,888 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MAIA now has a Market Capitalization of 54807816 and an Enterprise Value of 43916080.
Stock Price History:
The Beta on a monthly basis for MAIA is 0.00, which has changed by -0.291866 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, MAIA has reached a high of $2.74, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is 21.63%, while the 200-Day Moving Average is calculated to be -6.39%.
Shares Statistics:
The stock has traded on average 719.35K shares per day over the past 3-months and 910860 shares per day over the last 10 days, according to various share statistics. A total of 34.45M shares are outstanding, with a floating share count of 28.28M. Insiders hold about 20.00% of the company’s shares, while institutions hold 6.41% stake in the company. Shares short for MAIA as of 1765756800 were 1685137 with a Short Ratio of 2.34, compared to 1763078400 on 949543. Therefore, it implies a Short% of Shares Outstanding of 1685137 and a Short% of Float of 5.19.
Earnings Estimates
The stock of MAIA Biotechnology Inc (MAIA) is currently being evaluated by 1.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.18 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.74 and -$0.74 for the fiscal current year, implying an average EPS of -$0.74. EPS for the following year is -$0.69, with 1.0 analysts recommending between -$0.69 and -$0.69.
